Which cervical prep eases hysteroscopy for postmenopausal women?

NCT ID NCT07697781

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial tests whether preparing the cervix with medication before office hysteroscopy helps postmenopausal women have a more successful and less painful procedure. Participants are randomly assigned to receive either oral misoprostol, vaginal estrogen for 7 or 14 days, or no preparation at all. The study measures how often the hysteroscopy is completed successfully and how much pain women report during and after the procedure. The goal is to find the best way to make this common diagnostic exam more comfortable and effective for older women.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
misoprostol and vaginal estrogen
What this could lead to
If one preparation method works best, it could make office hysteroscopy easier and less painful for postmenopausal women, improving diagnosis of uterine conditions.
What could go wrong
This is a small, early-stage trial with 120 participants, so results may not apply to all women. The preparations themselves may cause side effects like cramping or irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABNORMAL UTERINE BLEEDING (AUB) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maternity and neonatology center of Tunis

    RECRUITING

    Tunis, Tunis Governorate, 1007, Tunisia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.